Related Experiment Video

Updated: May 1, 2026

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer
08:54

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Published on: June 13, 2019

10.4K

SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer

Guoqiang Li1, Weimin Ci2, Subhradip Karmakar3

  • 1Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China.

Cancer Cell
|March 25, 2014
PubMed

Insights

Hypoxia promotes clear cell renal cell carcinoma (ccRCC) by increasing SPOP, an E3 ubiquitin ligase. SPOP accumulation drives tumor growth by degrading tumor suppressors and proliferation regulators, making it a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Hypoxic stress and hypoxia-inducible factors (HIFs) are critical in tumor development.
  • Clear cell renal cell carcinoma (ccRCC) pathogenesis involves complex molecular signaling pathways.

Purpose of the Study:

  • To investigate the role of SPOP in ccRCC tumorigenesis under hypoxic conditions.
  • To identify SPOP as a direct transcriptional target of HIFs in ccRCC.
  • To elucidate the molecular mechanisms by which SPOP promotes ccRCC.

Main Methods:

  • Demonstration of SPOP as a direct transcriptional target of HIFs.
  • Analysis of SPOP's subcellular localization under hypoxia.
  • Investigation of SPOP's role in ubiquitination and degradation of key proteins.
  • Assessment of SPOP's impact on ccRCC cell viability via knockdown experiments.

Main Results:

  • SPOP is a direct transcriptional target of HIFs in ccRCC.
  • Hypoxia induces cytoplasmic accumulation of SPOP, promoting tumorigenesis.
  • SPOP-mediated degradation of PTEN, ERK phosphatases, Daxx, and Gli2 contributes to proliferation and apoptosis resistance.
  • Knockdown of SPOP selectively eliminates ccRCC cells.

Conclusions:

  • SPOP acts as a crucial regulatory hub in ccRCC tumorigenesis.
  • SPOP's function in degrading tumor suppressors and proliferation regulators highlights its oncogenic role.
  • SPOP represents a promising therapeutic target for ccRCC treatment.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

6.5K
Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

10.4K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K